• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非小细胞肺癌的分期

Staging of Non-Small-Cell Lung Cancer.

作者信息

Akhurst Tim

机构信息

Nuclear Medicine Service, Cancer Imaging, Peter MacCallum Cancer Centre, University of Melbourne, 305 Grattan Street, Melbourne, Victoria 3000, Australia.

出版信息

PET Clin. 2018 Jan;13(1):1-10. doi: 10.1016/j.cpet.2017.09.004. Epub 2017 Oct 26.

DOI:10.1016/j.cpet.2017.09.004
PMID:29157380
Abstract

Staging of lung cancer serves 2 purposes; it attempts to classify patients into groups where particular treatments are appropriate and defines those groups based on expected prognosis. The eighth edition of the International Association for the Study of Lung Cancer staging system deals with the issues raised by screening with fine cut computed tomography. Each phase of staging is a legitimate dataset on its own. Molecular profiling of lung cancer has led to the development of an increasing number of novel agents to treat systemic disease. Prognosis is increasingly determined by genetic susceptibility of the specific cancer.

摘要

肺癌分期有两个目的

它试图将患者分类到适合特定治疗的组中,并根据预期预后定义这些组。国际肺癌研究协会分期系统的第八版涉及了薄层计算机断层扫描筛查所引发的问题。分期的每个阶段本身都是一个合理的数据集。肺癌的分子谱分析已促使越来越多的新型药物用于治疗全身性疾病。预后越来越多地由特定癌症的遗传易感性决定。

相似文献

1
Staging of Non-Small-Cell Lung Cancer.非小细胞肺癌的分期
PET Clin. 2018 Jan;13(1):1-10. doi: 10.1016/j.cpet.2017.09.004. Epub 2017 Oct 26.
2
Role of FDG PET/CT in the Eighth Edition of TNM Staging of Non-Small Cell Lung Cancer.18F-FDG PET/CT 在第八版非小细胞肺癌 TNM 分期中的作用。
Radiographics. 2018 Nov-Dec;38(7):2134-2149. doi: 10.1148/rg.2018180060.
3
Dilemmas in Lung Cancer Staging.肺癌分期中的困境
Radiol Clin North Am. 2018 May;56(3):419-435. doi: 10.1016/j.rcl.2018.01.010.
4
Imaging in Lung Cancer Staging.肺癌分期中的影像学检查
Clin Chest Med. 2024 Jun;45(2):295-305. doi: 10.1016/j.ccm.2024.02.004. Epub 2024 Mar 28.
5
Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).支气管内与食管内超声联合用于肺癌诊断及分期:欧洲胃肠内镜学会(ESGE)指南,与欧洲呼吸学会(ERS)及欧洲胸外科医师学会(ESTS)合作制定
Endoscopy. 2015 Jun;47(6):545-59. doi: 10.1055/s-0034-1392040. Epub 2015 Jun 1.
6
Endobronchial ultrasound-guided transbronchial needle aspiration for lymph node staging in patients with non-small cell lung cancer in non-operable patients pursuing radiotherapy as a primary treatment.经支气管超声引导经支气管针吸活检术用于非手术患者中以放疗为主要治疗方法的非小细胞肺癌的淋巴结分期。
J Thorac Oncol. 2010 May;5(5):606-11. doi: 10.1097/JTO.0b013e3181d35627.
7
Mediastinal staging in Non-Small-Cell Lung Carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography.非小细胞肺癌的纵隔分期:计算机断层扫描与F-18-氟脱氧葡萄糖正电子发射断层扫描及计算机断层扫描对比
Cancer Imaging. 2014 Jun 3;14(1):23. doi: 10.1186/1470-7330-14-23.
8
[Computed tomography imaging of non-small cell lung cancer].[非小细胞肺癌的计算机断层扫描成像]
Cancer Radiother. 2016 Oct;20(6-7):694-8. doi: 10.1016/j.canrad.2016.08.125. Epub 2016 Sep 7.
9
Imaging of Lung Cancer Staging.肺癌分期的影像学检查。
Semin Respir Crit Care Med. 2022 Dec;43(6):862-873. doi: 10.1055/s-0042-1753476. Epub 2022 Jul 10.
10
Non-small cell lung cancer: prospective comparison of integrated FDG PET/CT and CT alone for preoperative staging.非小细胞肺癌:18F-FDG PET/CT 与单纯 CT 在术前分期中的前瞻性比较
Radiology. 2005 Sep;236(3):1011-9. doi: 10.1148/radiol.2363041310. Epub 2005 Jul 12.

引用本文的文献

1
MicroRNA155 in non-small cell lung cancer: a potential therapeutic target.非小细胞肺癌中的微小RNA155:一个潜在的治疗靶点。
Front Oncol. 2025 Feb 3;15:1517995. doi: 10.3389/fonc.2025.1517995. eCollection 2025.
2
miR-224-5p Suppresses Non-Small Cell Lung Cancer via IL6ST-Mediated Regulation of the JAK2/STAT3 Pathway.miR-224-5p通过IL6ST介导的JAK2/STAT3信号通路调控抑制非小细胞肺癌
Thorac Cancer. 2025 Jan;16(2):e15516. doi: 10.1111/1759-7714.15516.
3
Osimertinib in Early-Stage EGFR-Mutated Non-small Cell Lung Cancer: A Narrative Review of Its Impact on Survival, Safety, and Clinical Outcomes.
奥希替尼用于早期表皮生长因子受体(EGFR)突变的非小细胞肺癌:关于其对生存、安全性和临床结局影响的叙述性综述
Cureus. 2024 Nov 1;16(11):e72862. doi: 10.7759/cureus.72862. eCollection 2024 Nov.
4
Augmenting CT-Guided Bone Biopsies Using F-FDG PET/CT Guidance.使用F-FDG PET/CT引导增强CT引导下的骨活检
Cancers (Basel). 2024 Jul 29;16(15):2693. doi: 10.3390/cancers16152693.
5
Expression of RSK4 protein in non-small cell lung cancer tissues, adjacent tissues and its correlation with clinicopathological features.RSK4蛋白在非小细胞肺癌组织、癌旁组织中的表达及其与临床病理特征的相关性。
Am J Transl Res. 2024 Jul 15;16(7):3273-3279. doi: 10.62347/ZLEQ9498. eCollection 2024.
6
Radioisotope-Guided Excision of Mediastinal Lymph Nodes in Patients with Non-Small Cell Lung Carcinoma: Feasibility and Clinical Impact.放射性同位素引导下非小细胞肺癌患者纵隔淋巴结切除术:可行性及临床影响
Cancers (Basel). 2023 Jun 24;15(13):3320. doi: 10.3390/cancers15133320.
7
Construction of a prognostic model for lung adenocarcinoma based on membrane-tension-related genes.基于膜张力相关基因构建肺腺癌预后模型
J Thorac Dis. 2023 Apr 28;15(4):2098-2115. doi: 10.21037/jtd-23-396. Epub 2023 Apr 23.
8
Current therapy and development of therapeutic agents for lung cancer.肺癌的当前治疗方法及治疗药物的研发
Cell Insight. 2022 Feb 9;1(2):100015. doi: 10.1016/j.cellin.2022.100015. eCollection 2022 Apr.
9
The Use of Cytotoxic Drugs as First Line Chemotherapy for EGFR (+) Nonsquamous NSCLC: A Network Meta-Analysis.表皮生长因子受体(EGFR)阳性非鳞状非小细胞肺癌一线化疗中细胞毒药物的应用:一项网状荟萃分析。
Dis Markers. 2023 Apr 10;2023:5272125. doi: 10.1155/2023/5272125. eCollection 2023.
10
Resveratrol regulates -mediated mitophagy via the lncRNA axis, and enhances the antitumor activity of paclitaxel against non-small cell lung cancer.白藜芦醇通过长链非编码RNA轴调节介导的线粒体自噬,并增强紫杉醇对非小细胞肺癌的抗肿瘤活性。
Toxicol Res (Camb). 2022 Nov 5;11(6):962-974. doi: 10.1093/toxres/tfac072. eCollection 2022 Dec.